Terms: = Endocrine gland cancer AND ARNT, HIF1BETA, 405, ENSG00000143437, P27540, HIF-1beta, HIF1B, TANGO AND Staging
11 results:
1. Survival outcomes of epithelial ovarian cancer treated at a tertiary-level hospital in India.
Chandy RG; Thomas V; Sebastian A; Mani T; Thomas A; Joel A; Ram TS; Peedicayil A
Indian J Cancer; 2023 Oct; 60(4):475-485. PubMed ID: 38185864
[TBL] [Abstract] [Full Text] [Related]
2. Multi-Institutional Review of the Preoperative Diagnostic Accuracy for Pediatric Ovarian Mature Cystic Teratomas.
Knaus ME; Onwuka AJ; Afrazi A; Breech L; Corkum KS; Dillon PA; Ehrlich PF; Fallat ME; Fraser JD; Gadepalli SK; Grabowski JE; Hertweck SP; Kabre R; Lal DR; Landman MP; Lawrence AE; Leys CM; Mak GZ; Markel TA; Merchan N; Overman RE; Rademacher BL; Raiji MT; Rymeski B; Sato TT; Scannel M; Schikler AG; Sujka JA; Wright T; Aldrink JH; Hewitt GD; Minneci PC; Deans KJ;
J Pediatr Adolesc Gynecol; 2022 Aug; 35(4):478-485. PubMed ID: 35124214
[TBL] [Abstract] [Full Text] [Related]
3. Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation.
Healy GM; Salinas-Miranda E; Jain R; Dong X; Deniffel D; Borgida A; Hosni A; Ryan DT; Njeze N; McGuire A; Conlon KC; Dodd JD; Ryan ER; Grant RC; Gallinger S; Haider MA
Eur Radiol; 2022 Apr; 32(4):2492-2505. PubMed ID: 34757450
[TBL] [Abstract] [Full Text] [Related]
4. A simple risk score for detecting radiological occult metastasis in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma.
Sakaguchi T; Satoi S; Hashimoto D; Yamamoto T; Yamaki S; Hirooka S; Ishida M; Ikeura T; Inoue K; Sekimoto M
J Hepatobiliary Pancreat Sci; 2022 Feb; 29(2):262-270. PubMed ID: 34314568
[TBL] [Abstract] [Full Text] [Related]
5. Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian cancer by Bioinformatics Analysis.
Zhang J; Huang S; Quan L; Meng Q; Wang H; Wang J; Chen J
Biomed Res Int; 2021; 2021():8883800. PubMed ID: 33829065
[TBL] [Abstract] [Full Text] [Related]
6. Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer.
Turkdogan S; Forest VI; Hier MP; Tamilia M; Florea A; Payne RJ
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):55. PubMed ID: 30223887
[TBL] [Abstract] [Full Text] [Related]
7. Survival impact of low anterior resection in patients with epithelial ovarian cancer grossly confined to the pelvic cavity: a Korean multicenter study.
Kim M; Suh DH; Park JY; Paik ES; Lee S; Eoh KJ; Nam JH; Lee YY; Kim JW; Kim S
J Gynecol Oncol; 2018 Jul; 29(4):e60. PubMed ID: 29770630
[TBL] [Abstract] [Full Text] [Related]
8. Ultrasound texture analysis: Association with lymph node metastasis of papillary thyroid microcarcinoma.
Kim SY; Lee E; Nam SJ; Kim EK; Moon HJ; Yoon JH; Han KH; Kwak JY
PLoS One; 2017; 12(4):e0176103. PubMed ID: 28419171
[TBL] [Abstract] [Full Text] [Related]
9. Single nucleotide polymorphisms and mRNA expression of VEGF-A in papillary thyroid carcinoma: potential markers for aggressive phenotypes.
Salajegheh A; Smith RA; Kasem K; Gopalan V; Nassiri MR; William R; Lam AK
Eur J Surg Oncol; 2011 Jan; 37(1):93-9. PubMed ID: 21093207
[TBL] [Abstract] [Full Text] [Related]
10. Retroperitoneal laparoscopic lymph node dissection for staging non-seminomatous germ cell tumors before and after chemotherapy.
Rassweiler JJ; Henkel TO; Stock C; Seemann O; Frede T; Alken P
Lymphology; 1996 Mar; 29(1):36-44. PubMed ID: 8721978
[TBL] [Abstract] [Full Text] [Related]
11. Therapy and prognosis of testicular carcinomas in relation to TNM classification.
Batata MA; Chu FC; Hilaris BS; Papantoniou PA; Whitmore WF; Golbey RB
Int J Radiat Oncol Biol Phys; 1982 Aug; 8(8):1287-93. PubMed ID: 7141907
[TBL] [Abstract] [Full Text] [Related]
